Filing Details
- Accession Number:
- 0001179110-12-011622
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-07-17 20:48:58
- Reporting Period:
- 2012-07-13
- Filing Date:
- 2012-07-17
- Accepted Time:
- 2012-07-17 20:48:58
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1158223 | Affymax Inc | AFFY | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1230721 | Herb Cross | C/O Affymax, Inc. 4001 Miranda Ave. Palo Alto CA 94304 | Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2012-07-13 | 15,000 | $5.10 | 25,000 | No | 4 | M | Direct | |
Common Stock | Disposition | 2012-07-13 | 15,000 | $15.50 | 10,000 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2012-07-17 | 10,000 | $6.23 | 20,000 | No | 4 | M | Direct | |
Common Stock | Disposition | 2012-07-17 | 10,000 | $17.00 | 10,000 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (Right to Buy) | Disposition | 2012-07-13 | 15,000 | $0.00 | 15,000 | $5.10 |
Common Stock | Stock Option (Right to Buy) | Disposition | 2012-07-17 | 10,000 | $0.00 | 10,000 | $6.23 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
45,000 | 2020-11-14 | No | 4 | M | Direct | |
40,000 | 2021-03-03 | No | 4 | M | Direct |
Footnotes
- The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
- 1/4th of the shares vest one year after the vesting commencement date; the balance of the shares vest in a series of thirty-six (36) successive equal monthly installments measured from the first anniversary of the vesting commencement date.
- The option vests on a monthly basis in equal installments during the 48 month period beginning on March 4, 2011.